Have your own idea? Try our Stock Screener
German (DAX) Biotech Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies11
- 7D0.8%
- 3M1.1%
- 1Y-16.7%
- YTD-16.4%
Over the last 7 days, the Biotech industry has dropped 1.9%, driven by Formycon declining 1.8%. Meanwhile, 2invest actually outperformed within the industry, gaining 6.7% in the last week. Overall the industry is down 17% in 12 months. As for the next few years, earnings are expected to grow by 58% per annum.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | €2.6b | €764.0m | €46.5m | 13x | 55x | 3.3x |
| Sat, 19 Oct 2024 | €2.7b | €866.1m | €170.2m | 11.9x | 15.8x | 3.1x |
| Mon, 16 Sep 2024 | €2.6b | €867.2m | €174.8m | 12.2x | 14.7x | 3x |
| Wed, 14 Aug 2024 | €2.6b | €883.9m | €183.0m | 11.9x | 14.1x | 2.9x |
| Fri, 12 Jul 2024 | €2.7b | €884.7m | €209.8m | 12.9x | 13x | 3.1x |
| Sun, 09 Jun 2024 | €2.6b | €884.7m | €210.7m | 11.5x | 12.5x | 3x |
| Tue, 07 May 2024 | €2.6b | €786.7m | €160.8m | 10.8x | 16.4x | 3.4x |
| Thu, 04 Apr 2024 | €5.2b | €1.0b | -€179,474,613.00 | 9x | -28.9x | 5.1x |
| Sat, 02 Mar 2024 | €2.6b | €746.1m | -€35,822,108.00 | 12.5x | -73.6x | 3.5x |
| Mon, 29 Jan 2024 | €2.7b | €769.9m | -€145,885,802.00 | 12.7x | -18.7x | 3.6x |
| Wed, 27 Dec 2023 | €2.8b | €779.7m | -€160,010,802.00 | 13.5x | -17.6x | 3.6x |
| Fri, 24 Nov 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.6x | -18.1x | 3.7x |
| Sun, 22 Oct 2023 | €3.7b | €955.3m | -€172,995,145.00 | 9.9x | -21.1x | 3.8x |
| Tue, 19 Sep 2023 | €4.0b | €971.6m | -€197,588,171.00 | 11.3x | -20.1x | 4.1x |
| Thu, 17 Aug 2023 | €4.1b | €970.0m | -€15,743,772.00 | 20x | -260.6x | 4.2x |
| Sat, 15 Jul 2023 | €4.0b | €955.7m | -€219,213,323.00 | 26.2x | -18.3x | 4.2x |
| Mon, 12 Jun 2023 | €4.1b | €967.4m | -€212,660,026.00 | 31.5x | -19.5x | 4.3x |
| Wed, 10 May 2023 | €3.8b | €967.4m | -€209,726,026.00 | 32x | -17.9x | 3.9x |
| Fri, 07 Apr 2023 | €3.5b | €920.1m | -€215,190,985.00 | 13.6x | -16.2x | 3.8x |
| Sun, 05 Mar 2023 | €3.0b | €612.1m | -€74,530,062.00 | 10.7x | -40.1x | 4.9x |
| Tue, 31 Jan 2023 | €3.0b | €611.9m | -€53,407,435.00 | 10.7x | -55.7x | 4.9x |
| Thu, 29 Dec 2022 | €3.0b | €611.9m | -€53,407,435.00 | 11.1x | -56.2x | 4.9x |
| Sat, 26 Nov 2022 | €3.0b | €611.8m | -€48,604,435.00 | 11.1x | -62x | 4.9x |
| Mon, 24 Oct 2022 | €2.6b | €627.4m | -€129,805,157.00 | 6x | -19.7x | 4.1x |
| Wed, 21 Sep 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.4x | -20x | 4.1x |
| Fri, 19 Aug 2022 | €2.8b | €605.7m | -€150,021,513.00 | 6.3x | -18.6x | 4.6x |
| Sun, 17 Jul 2022 | €3.4b | €772.0m | -€724,268,362.00 | n/a | -4.6x | 4.4x |
| Tue, 14 Jun 2022 | €3.2b | €768.8m | -€724,082,241.00 | n/a | -4.5x | 4.2x |
| Thu, 12 May 2022 | €3.2b | €769.9m | -€723,863,944.00 | n/a | -4.4x | 4.1x |
| Sat, 09 Apr 2022 | €3.8b | €808.9m | -€704,269,813.00 | n/a | -5.4x | 4.7x |
| Mon, 07 Mar 2022 | €3.4b | €789.6m | -€311,283,353.00 | n/a | -11x | 4.3x |
| Wed, 02 Feb 2022 | €3.7b | €789.6m | -€311,283,353.00 | n/a | -12x | 4.7x |
| Fri, 31 Dec 2021 | €4.1b | €789.6m | -€311,690,565.00 | n/a | -13x | 5.1x |
| Sun, 28 Nov 2021 | €4.1b | €789.6m | -€311,690,565.00 | n/a | -13.1x | 5.2x |
Price to Earnings Ratio
-13.1x
Current Industry PE
- Investors are optimistic on the German Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 54.7x which is higher than its 3-year average PE of -14.2x.
- The 3-year average PS ratio of 4.1x is higher than the industry's current PS ratio of 3.3x.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable.
- Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.41% | |
| Healthcare | -3.73% | |
| Biotech | 0.75% | |
| Biotech | 0.75% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2INV 2invest | €11.10 | 6.7% +€4.0m | 79.0% | PE12.7x | |
| FYB Formycon | €47.05 | 0.2% +€1.8m | -23.6% | PE13x | |
| 8X4 Nidhogg Resources Holding | €0.0008 | 33.3% +€457.3k | n/a | n/a | |
| ECX Epigenomics | €1.15 | 11.7% +€105.0k | -51.3% | PE0.3x |